Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Key facts
- Who runs it
- Boston University
- Where
- Boston, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 26 Dec 2023
- Expected to end
- Jun 2028
- Type of study
- Observational
- Treatments tested
- Exposures
- Record updated
- 28 November 2025
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women only
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Women aged 18 to 50 years registering for antenatal care (ANC) at Government Medical College Hospital (GMC) Nagpur, India
- Estimated Gestational Age at registration <14 weeks based on ultrasound report at the baseline study visit
- Intends to receive pregnancy, labor and delivery and neonatal care at GMC
- Plans to live within the city limits of Nagpur throughout their pregnancy and labor and delivery to facilitate access to GMC for evaluation of ILI and COVID-19 symptoms
- Willing to be contacted two times per week by call or text for ILI/ COVID-19 symptom screening and return to GMC for evaluation and an NP swab/evaluation if symptoms are reported
- Willing to take temperature with the provided digital thermometer, and maintain a symptom diary after training
- Willing to provide information on pregnancy and neonatal outcomes if care occurs outside GMC
- Willing to permit venous blood draws on at least 4 timepoints --1) Baseline study visit, 2)28-34 weeks, 3) 37 weeks - prior to delivery and 4) after delivery
- Willing to permit blood draws if hospitalized at GMC for COVID-19 infection
- Willing to consent to participate in the study
Who cannot take part
- Anyone who is deemed to have limited decision-making capacity as defined by Boston University IRB i.e. Substantial impairment of cognitive functions (e.g. attention, comprehension, memory, and intellect), or conditions that might affect their cognitive functions
- Anyone who is deemed to have limited capacity to consent as defined by Boston University Institutional Review Board (IRB) i.e. The ability to provide legally effective consent to enroll in a research study (AAHRPP definition)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
This trial is currently available in United States.
Also in 1 other country, 1 site
- Boston University School of Public Health, Global HealthBoston, United StatesContact: Patricia Hibberd, MD PhDTaking people
About the trial
What the trial wants to find out
This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the obstetric department delivers about 10,000 babies a year. The hypothesis is that co-infection of other respiratory viruses (ORV), particularly COVID-19 and Influenza increases the risk of adverse pregnancy outcomes in mothers and babies and could address the current standard of care in India to not vaccinate pregnant women during pregnancy, by either encouraging vaccination against both viruses before planning a pregnancy or during pregnancy based on global data supporting the safety of this strategy.
The group in the trial
- Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE)
Pregnant women in their first trimester of pregnancy who present to the outpatient antenatal care clinic at Government Medical College Hospital in Nagpur, India.
Treatment: Exposures
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE) Study in India
- Criteria questions
- Built from NCT06168019, who can take part
- Record updated
- 28 November 2025